Modulation of VE-cadherin and PECAM-1 mediated cell-cell adhesions by mitogen-activated protein kinases

Journal of Cellular Biochemistry

Volumn 90, Issue 1, 2003, Pages 121-137

  Wu, Jianqiang ^a   Sheibani, Nader ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Adherens junction; Angiogenesis; CD31; Cell cell interactions; Endothelial cells

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CADHERIN; CATENIN; CD31 ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE; PHORBOL 13 ACETATE 12 MYRISTATE;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; DNA TRANSFECTION; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; GENETIC TRANSFECTION; INHIBITION KINETICS; MODULATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; WESTERN BLOTTING;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD31; CADHERINS; CELL ADHESION; CELL MOVEMENT; CELL SIZE; CELLS, CULTURED; COLLAGEN; DRUG COMBINATIONS; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; ENZYME INHIBITORS; LAMININ; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEOGLYCANS; SRC-FAMILY KINASES; TETRADECANOYLPHORBOL ACETATE; THROMBOSPONDIN 1; VANADATES;

EID: 0042320953     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.10600     Document Type: Article

References (55)

1. Bach TL, Barsigian C, Chalupowicz DG, Busler D, Yaen CH, Grant DS, Martinez J. 1998. VE-cadherin mediates endothelial cell capillary tube formation in fibrin and collagen gels. Exp Cell Res 238:324-334.
2. Brooks PC, Clark RA, Cheresh DA. 1994. Requirement of vascular integrin αvβ3 for angiogenesis. Science 264:569-571.
3. Cao G, O'brien CD, Zhou Z, Sanders SM, Greenbaum JN, Makrigiannakis A, DeLisser HM. 2002. Involvement of human PECAM-1 in angiogenesis and in vitro endothelial cell migration. Am J Physiol 282:C1181-C1190.
4. Carmeliet P, Lampugnani MG, Moons L, Breviario F, Compernolle V, Bono F, Balconi G, Spagnuolo R, Oostuyse B, Dewerchin M, Zanetti A, Angellilo A, Mattor V, Nuyens D, Lutgens E, Clotman F, de Ruiter MC, Gittenberger-de Groot A, Poelmann R, Lupu F, Herbert JM, Collen D, Dejana E. 1999. Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell 98:147-157.
5. Cohen AW, Carbajal JM, Schaeffer RC, Jr. 1999. VEGF stimulates tyrosine phosphorylation of β-catenin and small-pore endothelial barrier dysfunction. Am J Physiol 277:H2038-H2049.
6. Cottrell GT, Lin R, Warn-Cramer BJ, Lau AF, Burt JM. 2003. Mechanism of v-Src- and mitogen-activated protein kinase-induced reduction of gap junction communication. Am J Physiol Cell Physiol 284:C511-C520.
7. D'Angelo G, Struman I, Martial J, Weiner RI. 1995. Activation of mitogen-activated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the antiangiogenic factor 16-kDa N-terminal fragment of prolactin. Proc Natl Acad Sci USA 92:6374-6378.
8. Das M, Bouchey DM, Moore MJ, Hopkins DC, Nemenoff RA, Stenmark KR. 2001. Hypoxia-induced proliferative response of vascular adventitial fibroblasts is dependent on G-protein-mediated activation of mitogen-activated protein kinases. J Biol Chem 276:15631-15640.
9. Davis CM, Danehower SC, Laurenza A, Molony JL. 1993. Identification of a role of the vitronectin receptor and protein kinase c in the induction of endothelial cell vascular formation. J Cell Biochem 51:206-218.
10. Dejana E. 1996. Endothelial adherens junctions: Implications in the control of vascular permeability and angiogenesis. J Clin Invest 98:1949-1953.
11. Dejana E, Corada M, Lampugnani MG. 1995. Endothelial cell-to-cell junctions. FASEB J 9:910-918.
12. DeLisser HM, Christofidou-Solomidou M, Strieter RM, Burdiok MD, Robinson CS, Wexler RS, Kerr JS, Garlanda C, Merwin JR, Madri JA, Albelda SM. 1997. Involvement of endothelial PECAM-1/CD31 in angiogenesis. Am J Pathol 151:671-677.
13. Duncan GS, Andrew DP, Takimoto H, Kaufman SA, Yoshida H, Spellberg J, Luis de la Pompa J, Elis A, Wakeham A, Karan-Tamir B, Muller WA, Senaldi G, Zukowski MM, Mak TW 1999. Genetic evidence for functional redundancy of platelet/endothelial cell adhesion molecule-1 (PECAM-1): CD31-deficient mice reveal PECAM-1-dependent and PECAM-1-independent functions. J Immunol 162:3022-3030.
14. Eliceiri BP, Klemke R, Strömblad S, Cheresh DA. 1998. Integrin αvβ3 requirement for sustained mitogen-activated protein kinase activity during angiogenesis. J Cell Biol 140:1255-1263.
15. Eliceiri BP, Paul R, Schwartzberg PL, Hood JD, Leng J, Cheresh DA. 1999. Selective requirement for Src kinases during VEGF-mediated angiogenesis and vascular permeability. Mol Cell 4:915-924.
16. Eliceiri BP, Puente XS, Hood JD, Stupack DG, Schlaepfer DD, Huang XZ, Sheppard D, Cheresh DA. 2002. Src-mediated coupling of focal adhesion kinase to integtrin αvβ5 in vascular endothelial growth factor signaling. J Cell Biol 157:149-159.
17. Esser S, Lampugnani MG, Corada M, Dejana E, Risau W. 1998. Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells. J Cell Sci 111:1853-1865.
18. Giroux S, Tremblay M, Bernard D, Cadrin-Girard JF, Aubry S, Larouche L, Rousseau S, Huot J, Landry J, Jeannotte L, Charron J. 1998. Embryonic death of Mekl-deficient mice reveals a role for this kinase in angiogenesis in the labyrinthine region of the placenta. Curr Biol 9:369-372.
19. 1/2 in urokinase-type plasminogen activator upregulation and in vitro angiogenesis by fibroblast growth factor-2. J Cell Sci 112:2597-2606.
20. Graesser D, Solowiej A, Bruckner M, Osterweil E, Juedes A, Davis S, Ruddle NH, Engelhardt B, Madri JA. 2002. Altered vascular permeability and early onset of experimental autoimmune encephalomyelitis in PECAM-1-deficient mice. J Clin Invest 109:383-392.
21. Hordijk PL, Anthony E, Mul FPJ, Rientsma CJ, Oomen LCJM, Roos D. 1999. Vascular-endothelial-cadherin modulates endothelial monolayer permeability. J Cell Sci 112:1915-1923.
22. Hughes PE, Renshaw MW, Pfaff M, Forsyth J, Keivens VM, Schwartz MA, Ginsberg MH. 1997. Suppression of integrin activation: A novel function of a Ras/Raf-initiated MAP kinase pathway. Cell 88:521-530.
23. Hynes RO. 2002. Integrins: Bi-directional, allosteric signaling machines. Cell 110:673-687.
24. Kim S, Bell K, Mousa SA, Varner JA. 2000a. Regulation of angiogenesis in vivo by ligation of integrin α5β1 with the central cell-binding domain of fibronectin. Am J Pathol 156:1345-1362.
25. Kim S, Harris M, Varner JA. 2000b. Regulation of integrin αvβ3-mediated endothelial cell migration and angiogenesis by integrin α5β1 and protein kinase A. J Biol Chem 275:33920-33928.
26. Klemke RL, Cai S, Giannini AL, Gallagher PJ, de Lanerolle P, Cheresh DA. 1997. Regulation of cell motility by mitogen-activated protein kinase. J Cell Biol 137:481-492.
27. Kroll J, Waltenberger J. 1997. The vascular endothelial growth factor receptor KDR activates multiple signal transduction pathways in porcine aortic endothelial cells. J Biol Chem 272:32521-32527.
28. Lampugnani MG, Corada M, Caveda L, Breviario F, Ayalon O, Geiger B, Dejana E. 1995. The molecular organization of endothelial cell-to-cell junctions: Differential association of plakoglobin, β-catenin, and α-catenin with vascular endothelial cadherin (VE-cadherin). J Cell Biol 129:203-217.
29. LaVallee TM, Prudovsky IA, McMahon G, Hu X, Maciag T. 1998. Activation of the MAP kinase pathway by FGF-1 correlates with cell proliferation induction while activation of the src pathway correlates with migration. J Cell Biol 141:1647-1658.
30. Matsumura T, Wolff K, Petzelbauer P. 1997. Endothelial cell tube formation depends on cadherin 5 and CD31 interactions with filamentous actin. J Immun 158:3408-3416.
31. McCawley LJ, Li S, Wattenberg EV, Hudson LG. 1998. Sustained activation of the mitogen-activated protein kinase pathway. J Biol Chem 274:4347-4353.
32. Mucha DR, Myers CL, Schaeffer RC, Jr. 2003. Endothelial contraction and monolayer hyperpermeability are regulated by Src kinase. Am J Physiol Heart Circ Physiol 284:H994-H1002.
33. Owens DW, McLean GW, Wyke AW, Paraskeva C, Parkinson EK, Frame MC, Brunton VG. 2000. The catalytic activity of the Src family kinases is required to disrupt cadherin-dependent cell-cell contacts. Mol Biol Cell 11:51-64.
34. Ozawa M, Kemler R. 1998. Altered cell adhesion activity by pervanadate due to the dissociation of α-catenin from the E-cadherin-catenin complex. J Biol Chem 273:6166-6170.
35. Pedram A, Razandi M, Levin ER. 1998. Extracellular signal-regulated protein kinase/Jun kinase cross-talk underlies vascular endothelial cell growth factor-induced endothelial cell proliferation. J Biol Chem 273:26722-26728.
36. Rabiet MJ, Plantier JL, Rival Y, Genoux Y, Lampugnani MG, Dejana E. 1996. Thrombin-induced increase in endothelial permeability is associated with changes in cell-to-cell juntion organization. Arterioscler Thromb Vasc Biol 16:488-496.
37. Schimmenti LA, Yan HC, Madri JA, Albelda SM. 1992. Platelet endothelial cell adhesion molecule, PECAM-1, modulates cell migration. J Cell Physiol 153:417-428.
38. Schmitt JM, Stork PJS. 2002. PKA phosphorylation of Src mediates cAMP's inhibition of cell growth via Rap1. Mol Cell 9:85-94.
39. Schnittler HJ, Puschel B, Drenckhahn D. 1997. Role of cadherins and plakoglobin in interendothelial adhesion under resting conditions and shear stress. Am J Physiol 273:H2396-H2405.
40. Sheibani N, Frazier WA. 1995. Thrombospondin 1 expression in transformed endothelial cells restores a normal phenotype and suppresses their tumorigenesis. Proc Natl Acad Sci USA 92:6788-6792.
41. Sheibani N, Frazier WA. 1998. Down-regulation of platelet endothelial cell adhesion molecule-1 results in thrombospondin-1 expression and concerted regulation of endothelial cell phenotype. Mol Biol Cell 9:701-713.
42. Sheibani N, Frazier WA. 1999. Thrombospondins, PECAM-1, and regulation of angiogenesis. Histol Histopathol 14:285-294.
43. Sheibani N, Newman PJ, Frazier WA. 1997. Thrombospondin-1, a natural inhibitor of angiogenesis, regulates platelet-endothelial cell adhesion molecule-1 expression and endothelial cell morphogenesis. Mol Biol Cell 8:1329-1341.
44. Sheibani N, Sorenson CM, Frazier WA. 1999. Tissue specific expression of alternatively spliced murine PECAM-1 isoforms. Dev Dyn 214:44-54.
45. Sheibani N, Sorenson CM, Frazier WA. 2000. Differential modulation of cadherin-mediated cell-cell adhesion by platelet endothelial cell adhesion molecule-1 isoforms through activation of extracellular regulated kinases. Mol Biol Cell 11:2793-2802.
46. Shi S, Garcia JGN, Roy S, Parinandi NL, Natarajan V. 2000. Involvement of c-Src in diperoxovanadate-induced endothelial cell barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 279:L441-L451.
47. Tanimura S, Nomura K, Ozaki K, Tsujimoto M, Kondo T, Kohno M. 2002. Prolonged nuclear retention of activated extracellular signal-regulated kinase 1/2 is required for hepatocyte growth factor-induced cell motility. J Biol Chem 277:28256-28264.
48. Venkiteswaran K, Xiao K, Summers S, Calkins CC, Vincent PA, Pumiglia K, Kowalczyk AP. 2002. Regulation of endothelial barrier function and growth by VE-cadherin, plakoglobin, and β-catenin. Am J Physiol 283:C811-C821.
49. Vittet D, Buchou T, Schweitzer A, Dejana E, Huber P. 1997. Targeted null-mutation in the vascular endothelial-cadherin gene impairs the organization of vascular-like structures in embryoid bodies. Proc Natl Acad Sci USA 94:6273-6278.
50. Vin̄als F, Pouysségur J. 1999. Confluence of vascular endothelial cells induces cell cycle exit by inhibiting p42/p44 mitogen-activated protein kinase activity. Mol Cell Biol 19:2763-2772.
51. Wang A, Nomura M, Patan S, Ware JA. 2002. Inhibition of protein kinase Cα prevents endothelial cell migration and vascular tube formation in vitro and myocardial neovascularization in vivo. Circ Res 90:609-616.
52. Xia P, Aiello LP, Ishii H, Jiang ZY, Park DJ, Robinson GS, Takagi H, Newsome WP, Jirousek MR, King GL. 1996. Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. J Clin Invest 98:2018-2026.
53. Yang S, Graham J, Kahn JW, Schwartz EA, Gerritsen ME. 1999. Functional roles for PECAM-1 (CD31) and VE Cadherin (CD144) in tube assembly and lumen formation in three-dimensional collagen gels. Am J Pathol 155:887-895.
54. Yashima R, Abe M, Tanaka K, Ueno H, Shitara K, Takenoshita S, Sato Y. 2001. Heterogeneity of the signal transduction pathways for VEGF-induced MAPKs activation in human vascular endothelial cells. J Cell Physiol 188:201-210.
55. Zanetti A, Lampugnani MG, Balconi G, Breviario F, Corada M, Lanfrancone L, Dejana E. 2002. Vascular endothelial growth factor induces shc association with vascular endothelial cadherin. Arterioscler Thromb Vasc Biol 22:617-622.